Dr. Joe Mendez, MD
Claim this profileHuntsman Cancer Institute/University of Utah
Area of expertise
Brain Tumor
Joe Mendez, MD has run 7 trials for Brain Tumor. Some of their research focus areas include:
Glioblastoma
Joe Mendez, MD has run 5 trials for Glioblastoma. Some of their research focus areas include:
Affiliated Hospitals
Huntsman Cancer Institute/University Of Utah
University Of Utah Huntsman Cancer Institute
Clinical Trials Joe Mendez, MD is currently running
Multiple Targeted Therapies
for Meningioma
This trial studies four drugs to treat patients with worsening meningioma. These drugs work by blocking enzymes that the tumor cells need to grow. The trial focuses on patients whose tumors have specific genetic mutations.
Recruiting
1 award
Phase 2
10 criteria
Lomustine + Standard Therapy
for Glioblastoma
This phase III trial compares the effect of adding lomustine to standard chemotherapy with temozolomide and radiation therapy versus temozolomide and radiation therapy alone in shrinking or stabilizing newly diagnosed MGMT methylated glioblastoma. MGMT methylated tumors are more likely to respond to temozolomide chemotherapy. Temozolomide is in a class of medications called alkylating agents. It works by damaging the cell's DNA and may kill tumor cells and slow down or stop tumor growth. Lomustine is a chemotherapy drug and in a class of medications called alkylating agents. It damages the cell's DNA and may kill tumor cells. Radiation therapy uses high energy x-ray photons to kill tumor cells and shrink tumors. Adding lomustine to standard chemotherapy with temozolomide and radiation therapy may shrink or stabilize glioblastoma.
Recruiting
2 awards
Phase 3
4 criteria
More about Joe Mendez, MD
Clinical Trial Related
7 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Joe Mendez, MD has experience with
- ONC201
- Nivolumab
- Ipilimumab
- Tirabrutinib
- Radiation Therapy
- Stereotactic Radiosurgery
Breakdown of trials Joe Mendez, MD has run
Brain Tumor
Glioblastoma
Mesial Temporal Sclerosis
Gliosarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Joe Mendez, MD specialize in?
Joe Mendez, MD focuses on Brain Tumor and Glioblastoma. In particular, much of their work with Brain Tumor has involved SMO positive patients, or patients who are PTCH1 positive.
Is Joe Mendez, MD currently recruiting for clinical trials?
Yes, Joe Mendez, MD is currently recruiting for 4 clinical trials in Salt Lake City Utah. If you're interested in participating, you should apply.
Are there any treatments that Joe Mendez, MD has studied deeply?
Yes, Joe Mendez, MD has studied treatments such as ONC201, Nivolumab, Ipilimumab.
What is the best way to schedule an appointment with Joe Mendez, MD?
Apply for one of the trials that Joe Mendez, MD is conducting.
What is the office address of Joe Mendez, MD?
The office of Joe Mendez, MD is located at: Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah 84112 United States. This is the address for their practice at the Huntsman Cancer Institute/University of Utah.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.